Press Release | Wed May 14, 2014 5:00pm EDT

Dendreon Announces Presentation of PROVENGE® (sipuleucel-T) and DN24-02 Immuno-Oncology Data at the 2014 ASCO Annual Meeting

* Reuters is not responsible for the content in this press release.